Angola vs China: Tuberculosis patients living with HIV receiving antiretroviral therapy

Angola
3,597 patients
in 2021
China
4,711 patients
in 2021
Angola rank
17th
China rank
14th

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Angola
  • China
02.0k4.0k6.0k200620132021

How they compare

China currently reports 4,711 patients against 3,597 patients in Angola, a difference of 1,114 patients.

That makes China's figure about 1.3 times Angola's.

Across all 9 years both countries report, China has been ahead every year.

Angola ranks 17th and China ranks 14th of 183 countries.

China has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Angola China Difference Ahead
2000s 44.5 patients 795.5 patients 751 patients China
2010s 1,716 patients 4,044 patients 2,328 patients China
2020s 3,564 patients 4,999 patients 1,436 patients China

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Angola or China?
China, at 4,711 patients against 3,597 patients in Angola as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Angola and China?
1,114 patients, with China ahead.
How many years of comparable data are there for Angola and China?
9 years are reported by both, from 2007 to 2021.
How do Angola and China rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Angola ranks 17th and China ranks 14th of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Angola vs China: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 09 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/angola/china/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/angola/china/">Angola vs China: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.